| Timothy Lu, M.D., Ph.D. | Chief Executive Officer | FY2024 | |
| Kanya Rajangam, M.D., Ph.D. | President, Head of Research and Development and Chief Medical Officer | FY2024 | |
| Yvonne Li | Interim Chief Financial Officer | FY2024 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.